← Back to Search

Peer-buddy system for Obstructive Sleep Apnea

N/A
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30, day 90, and day 180
Awards & highlights

Study Summary

Obstructive sleep apnea (OSA) is a prevalent condition that affects 7 to 12% of the US population and is characterized by repetitive collapse of the upper airway during sleep. Continuous positive airway pressure (CPAP) has been shown to be highly effective in the treatment of OSA, however, adherence is poor with up to 54% of patients being non-adherent to CPAP therapy by Medicare criteria, which has been attributed to inadequate patient education and support for CPAP therapy. Poor treatment adherence in patients with OSA can lead to adverse health consequences, poor quality of life, and patient dissatisfaction. Poor treatment adherence may be due to lack of sufficient patient education, time delays in delivery of care, lack of adequate healthcare coordination, or difficulty accessing various healthcare providers across a front desk which serves as a "healthcare bottle-neck". Better efficiency in healthcare delivery, with greater connectivity through knowledgeable and trained peer volunteers and cheap cell-phones integrated by a smart telephone exchange may alleviate some of the care and communication burden faced by the healthcare system. Specifically, such community health education volunteers ("peer-buddies") who are experienced in managing their OSA may be able to impart knowledge and confidence to a recently diagnosed patient in a much more personalized manner than that of a group therapy session.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 90, and day 180
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 90, and day 180 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients undergoing sleep study testing
Secondary outcome measures
CPAP Adherence downloads
Other outcome measures
Body Mass Index (BMI)
Diastolic blood pressure
Epworth Sleepiness Scale
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer-buddy systemExperimental Treatment1 Intervention
Will meet with peer-buddy who will help with them with CPAP usage. Also will receive standard of care CPAP educational training
Group II: Usual CareActive Control1 Intervention
Will receive educational material at the same frequency that those in the experimental arm. Will also receive standard of care CPAP educational training.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
514 Previous Clinical Trials
147,826 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,830 Previous Clinical Trials
47,302,609 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~20 spots leftby Apr 2025